CapitaLands 14 Billion Geneo Hub Set to Transform Singapores Life Sciences Landscape Whale Activity Detected in 10 Information Technology Stocks Benzinga Reports Tech Billionaires Sway Trump to Abandon AI Executive Order Amidst Regulatory Divisions Huawei Unveils Advanced Chip Design Method Amid Intensifying AI Chip Rivalry with Nvidia and Apple BSE and NSE to Observe Holiday on May 28 for Bakri Id Markets to Remain Closed Dow Jones Reaches Record High Above 50600 as Oil Prices Dip Below 90 TRI Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Amid Steady Business Performance GBFH Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises Slightly GCI Liberty Inc Series C GLIBK Q1 2026 Earnings EPS Misses Estimates by 6389 Stock Slides CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66 ODYS Q1 2026 Earnings WiderthanExpected Loss Pressures Shares as Revenue Remains Absent CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction ASP Isotopes ASPI Surges 2486 Key Levels and Potential Drivers AbCellera Biologics ABCL Edges Higher as Biotech Sentiment Stabilizes Skeena Resources Slips 35 as Bearish Pressure Tests Key Support Levels SKE Ivanhoe Electric Inc IE Surges Over 10 Key Technical Levels and Sector Dynamics Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Trading Remains Muted Biotech Sector Outlook 2026 Key Trends and Investment Considerations Covenant Logistics Group CVLG Q1 2026 Earnings EPS Slightly Below Estimates Stock Gains 385 JBS NV JBS Declines as Market Pressures Mount Key Levels to Watch COUR Q1 2026 Earnings EPS Miss but Stock Rises on Operational Resilience Avino Silver Gold Mines Ltd ASM Q1 2026 Earnings Earnings Beat Strong Yet Stock Pulls Back STAG Q1 2026 Earnings Stellar EPS Surprise Drives Cautious Optimism SYRE Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 American Realty Investors Inc Q3 2024 Earnings Negative EPS of 108 as Losses Persist Stock Declines MBX Q1 2026 Earnings Narrower Loss Exceeds Expectations Amid Clinical Development Progress